Interaction of acute lymphopblastic leukemia cells with C-type lectins DC-SIGN and L-SIGN

Experimental Hematology

Volumn 36, Issue 7, 2008, Pages 860-870

  Gijzen, Karlijn ^a   Raymakers, Reinier A P ^b   Broers, Karin M ^a   Figdor, Carl G ^a   Torensma, Ruurd ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD209 ANTIGEN; CD299 ANTIGEN; LECTIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLOOD CELL; BONE MARROW CELL; CANCER PATIENT; CELL INTERACTION; CIRCULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKEMIA CELL; LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN BINDING;

ADOLESCENT; ADULT; BONE MARROW CELLS; BURKITT LYMPHOMA; CARBOHYDRATES; CELL ADHESION MOLECULES; CHILD; CHILD, PRESCHOOL; DENDRITIC CELLS; DISEASE-FREE SURVIVAL; ENDOTHELIAL CELLS; FEMALE; GLYCOSYLATION; HUMANS; IMMUNE TOLERANCE; LECTINS, C-TYPE; LEUKEMIA-LYMPHOMA, ADULT T-CELL; LIVER; MALE; MIDDLE AGED; PROTEIN BINDING; RECEPTORS, CELL SURFACE; SURVIVAL RATE;

EID: 52449135487     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2008.02.003     Document Type: Article

References (44)

1. Harris N.L., Jaffe E.S., Diebold J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17 (1999) 3835-3849
2. Pui C.H., and Evans W.E. Treatment of acute lymphoblastic leukemia. N Engl J Med 354 (2006) 166-178
3. Lenkei R., Bjork O., Ost A., and Biberfeld P. Expression of CD15 as predictor of relapse in children with acute lymphoblastic leukemia of the pre-B type. Leuk Res 15 (1991) 189-194
4. Plasschaert S.L., Kamps W.A., Vellenga E., de Vries E.G., and de Bont E.S. Prognosis in childhood and adult acute lymphoblastic leukaemia: a question of maturation?. Cancer Treat Rev 30 (2004) 37-51
5. Pui C.H., and Evans W.E. Acute lymphoblastic leukemia. N Engl J Med 339 (1998) 605-615
6. Couldrey C., and Green J.E. Metastases: the glycan connection. Breast Cancer Res 2 (2000) 321-323
7. McCann K.J., Johnson P.W.M., Stevenson F.K., and Ottensmeier C.H. Universal N-glycosylation sites introduced into the B-cell receptor of follicular lymphoma by somatic mutation: a second tumorigenic event?. Leukemia 20 (2006) 530-534
8. Dube D.H., and Bertozzi C.R. Glycans in cancer and inflammation-potential for therapeutics and diagnostics. Nat Rev Drug Discov 4 (2005) 477-488
9. Drickamer K. C-type lectin-like domains. Curr Opin Struct Biol 9 (1999) 585-590
10. Cambi A., and Figdor C.G. Dual function of C-type lectin-like receptors in the immune system. Curr Opin Cell Biol 15 (2003) 539-546
11. Cambi A., and Figdor C.G. Levels of complexity in pathogen recognition by C-type lectins. Curr Opin Immunol 17 (2005) 1-7
12. McGreal E.P., Martinez-Pomares L., and Gordon S. Divergent roles for C-type lectins expressed by cells of the innate immune system. Mol Immunol 41 (2004) 1109-1121
13. Gijzen K., Tacken P.J., Zimmerman A., et al. Relevance of DC-SIGN in DC-induced T cell proliferation. J Leukoc Biol 81 (2007) 729-740
14. Geijtenbeek T.B., Torensma R., Van Vliet S.J., et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100 (2000) 575-585
15. Gijzen K., Cambi A., Torensma R., and Figdor C.G. C-type lectins on dendritic cells and their interaction with pathogen-derived and endogenous glycoconjugates. Curr Protein Pept Sci 7 (2006) 283-294
16. Guo Y., Feinberg H., Conroy E., et al. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR. Nat Struct Mol Biol 11 (2004) 591-598
17. Bashirova A.A., Geijtenbeek T.B., van Duijnhoven G.C., et al. A dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN)-related protein is highly expressed on human liver sinusoidal endothelial cells and promotes HIV-1 infection. J Exp Med 193 (2001) 671-678
18. Soilleux E.J., Barten R., and Trowsdale J. DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13. J Immunol 165 (2000) 2937-2942
19. Knolle P.A., and Limmer A. Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells. Trends Immunol 22 (2001) 432-437
20. Limmer A., Ohl J., Kurts C., et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat Med 6 (2000) 1348-1354
21. Van Liempt E., Imberty A., Bank C.M., et al. Molecular basis of the differences in binding properties of the highly related C-type lectins DC-SIGN and L-SIGN to Lewis X trisaccharide and Schistosoma mansoni egg antigens. J Biol Chem 279 (2004) 33161-33167
22. Meyer S., Tefsen B., Imberty A., Geyer R., and van Die I. The C-type lectin L-SIGN differentially recognizes glycan antigens on egg glycosphingolipids and soluble egg glycoproteins from Schistosoma mansoni. Glycobiology 17 (2007) 1104-1119
23. Gijzen K., Broers K.M., Beeren I.M., Figdor C.G., and Torensma R. Binding of the adhesion and pathogen receptor DC-SIGN by monocytes is regulated by the density of Lewis X molecules. Mol Immunol 44 (2007) 2481-2486
24. Snyder G.A., Colonna M., and Sun P.D. The structure of DC-SIGNR with a portion of its repeat domain lends insights to modeling of the receptor tetramer. J Mol Biol 347 (2005) 979-989
25. Ryan E.J., Marshall A.J., Magaletti D., et al. Dendritic cell-associated lectin-1: a novel dendritic cell-associated, C-type lectin-like molecule enhances T cell secretion of IL-4. J Immunol 169 (2002) 5638-5648
26. Dakappagari N., Maruyama T., Renshaw M., et al. Internalizing antibodies to the C-type lectins, L-SIGN and DC-SIGN, inhibit viral glycoprotein binding and deliver antigen to human dendritic cells for the induction of T cell responses. J Immunol 176 (2006) 426-440
27. Thomas T.C., Rollins S.A., Rother R.P., et al. Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv. Mol Immunol 33 (1996) 1389-1401
28. Geijtenbeek T.B., van Kooyk Y., Van Vliet S.J., Renes M.H., Raymakers R.A., and Figdor C.G. High frequency of adhesion defects in B-lineage acute lymphoblastic leukemia. Blood 94 (1999) 754-764
29. Daniels M.A., Hogquist K.A., and Jameson S.C. Sweet 'n' sour: the impact of differential glycosylation on T cell responses. Nat Immunol 3 (2002) 903-910
30. van Dongen J.J., Quertermous T., Bartram C.R., et al. T cell receptor-CD3 complex during early T cell differentiation. Analysis of immature T cell acute lymphoblastic leukemias (T-ALL) at DNA, RNA, and cell membrane level. J Immunol 138 (1987) 1260-1269
31. van Gisbergen K.P., Aarnoudse C.A., Meijer G.A., Geijtenbeek T.B., and van Kooyk Y. Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin. Cancer Res 65 (2005) 5935-5944
32. Maynadie M., Campos L., Moskovtchenko P., et al. Heterogenous expression of CD15 in acute lymphoblastic leukemia: a study of ten anti-CD15 monoclonal antibodies in 158 patients. Leuk Lymphoma 25 (1997) 135-143
33. Appelmelk B.J., Van D.I., Van Vliet S.J., Vandenbroucke-Grauls C.M., Geijtenbeek T.B., and van Kooyk Y. Carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol 170 (2003) 1635-1639
34. Benharroch D., Dima E., Levy A., et al. Differential expression of sialyl and non-sialyl-CD15 antigens on Hodgkin-Reed-Sternberg cells: significance in Hodgkin's disease. Leuk Lymphoma 39 (2000) 185-194
35. Lavabre-Bertrand T., Duperray C., Brunet C., et al. Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B-cell maturation stages: relevance for the study of B-cell neoplasias. Leukemia 8 (1994) 402-408
36. Goochee C.F., and Monica T. Environmental effects on protein glycosylation. Biotechnology 8 (1990) 421-427
37. Luczynski W., Stasiak-Barmuta A., Ilendo E., et al. Low expression of costimulatory molecules and mRNA for cytokines are important mechanisms of immunosuppression in acute lymphoblastic leukemia in children?. Neoplasma 53 (2006) 301-304
38. Yotnda P., Mintz P., Grigoriadou K., Lemonnier F., Vilmer E., and Langlade-Demoyen P. Analysis of T-cell defects in the specific immune response against acute lymphoblastic leukemia cells. Exp Hematol 27 (1999) 1375-1383
39. Ebata K., Shimizu Y., Nakayama Y., et al. Immature NK cells suppress dendritic cell functions during the development of leukemia in a mouse model. J Immunol 176 (2006) 4113-4124
40. Fricke I., and Gabrilovich D.I. Dendritic cells and tumor microenvironment: a dangerous liaison. Immunol Invest 35 (2006) 459-483
41. Geijtenbeek T.B., Van Vliet S.J., Engering A., 't Hart B.A., and van Kooyk Y. Self- and nonself-recognition by C-type lectins on dendritic cells. Annu Rev Immunol 22 (2004) 33-54
42. Bergman M.P., Engering A., Smits H.H., et al. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med 200 (2004) 979-990
43. Geijtenbeek T.B., Van Vliet S.J., Koppel E.A., et al. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 197 (2003) 7-17
44. Lai W.K., Sun P.J., Zhang J., et al. Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium: a role for capturing hepatitis C virus particles. Am J Pathol 169 (2006) 200-208